Cargando…

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer

Pancreatic cancer is characterized by an immunosuppressive tumor microenvironment (TME) with a profound immune infiltrate populated by a significant number of myeloid-derived suppressor cells (MDSCs). MDSCs have been increasingly recognized for their role in immune evasion and cancer progression as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jinhoi, Lee, Jaemin, Kim, Jinsil, Jo, Seongyea, Kim, Yeon Jeong, Baek, Ji Eun, Kwon, Eun-Soo, Lee, Kwang-Pyo, Yang, Siyoung, Kwon, Ki-Sun, Kim, Dong-Uk, Kang, Tae Heung, Park, Yun-Yong, Chang, Suhwan, Cho, Hee Jun, Kim, Song Cheol, Koh, Sang Seok, Kim, Seokho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239518/ https://www.ncbi.nlm.nih.gov/pubmed/27322081 http://dx.doi.org/10.18632/oncotarget.10123

Ejemplares similares

CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors
por: Lee, Jaemin, et al.
Publicado: (2016)

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2018)

PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer
por: Kim, Yeon Jeong, et al.
Publicado: (2022)

Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor
por: Yoo, Wonbeak, et al.
Publicado: (2021)

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells
por: Cho, Jae Hee, et al.
Publicado: (2017)

PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway
por: Youn, So Eun, et al.
Publicado: (2022)

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
por: Kang, Tae Heung, et al.
Publicado: (2015)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target
por: Yoo, Wonbeak, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2021)

A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells
por: Kim, Inki, et al.
Publicado: (2018)

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model
por: Jung, Jae Yun, et al.
Publicado: (2021)

Anti-Itching and Anti-Inflammatory Effects of Kushenol F via the Inhibition of TSLP Production
por: Jo, Seongyea, et al.
Publicado: (2022)

Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature
por: Jung, Jaeyun, et al.
Publicado: (2016)

Downregulation of X-linked inhibitor of apoptosis protein by ‘7-Benzylidenenaltrexone maleate’ sensitizes pancreatic cancer cells to TRAIL-induced apoptosis
por: Kim, So Young, et al.
Publicado: (2017)

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)

Diversity in the Extracellular Vesicle-Derived Microbiome of Tissues According to Tumor Progression in Pancreatic Cancer
por: Jeong, Jin-Yong, et al.
Publicado: (2020)

Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
por: Lee, Woohyung, et al.
Publicado: (2020)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
por: Lee, Sung Hwan, et al.
Publicado: (2015)

Stereotactic body radiation therapy for locally advanced pancreatic cancer
por: Jung, Jinhong, et al.
Publicado: (2019)

Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
por: Shou, Dawei, et al.
Publicado: (2016)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
por: Wang, Botao, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)

Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo
por: Zhang, Jian, et al.
Publicado: (2008)

Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs)
por: Nam, Sorim, et al.
Publicado: (2019)

An Impacted Pancreatic Stone in the Papilla Induced Acute Obstructive Cholangitis in a Patient with Chronic Pancreatitis
por: Yoo, Kwang-Ho, et al.
Publicado: (2012)

Association between Smoking and the Progression of Computed Tomography Findings in Chronic Pancreatitis
por: Lee, Jeong Woo, et al.
Publicado: (2016)

Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer
por: Yi, Joo Mi, et al.
Publicado: (2017)

A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model
por: Wu, Guang, et al.
Publicado: (2018)

A Case of Primary Pancreatic Non-Hodgkin's Lymphoma
por: Lee, Myung-Kwon, et al.
Publicado: (2006)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
por: Okła, Karolina
Publicado: (2023)

Apoptosis inhibitor 5 increases metastasis via Erk-mediated MMP expression
por: Song, Kwon-Ho, et al.
Publicado: (2015)

SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
por: Kim, Young Eun, et al.
Publicado: (2021)

Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
por: Park, Jiyoung, et al.
Publicado: (2017)

Analysis of MicroRNA Signature Differentially Expressed in Pancreatic Islet Cells Treated with Pancreatic Cancer-Derived Exosomes
por: Kim, Young-gon, et al.
Publicado: (2023)

Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only
por: Shin, Su-Jin, et al.
Publicado: (2018)

Importance of Pancreatic Duct Stenting and Enteral Feeding in Treatment Algorithm of Pancreatic Fluid Collections
por: Kim, Seong-Hun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmq415unnns3ge434v0skdpikk